PRICE T ROWE ASSOCIATES INC 13D/13G Filings for Eucrates Biomedical Acquisition Corp. (EUCRU)

PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Eucrates Biomedical Acquisition Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Eucrates Biomedical Acquisition Corp.
EUCRU
PRICE T ROWE ASSOCIATES INC 730,864
5.400%
730,864increase
(New Position)
Filing